FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

174 letters match. Newest first.

  1. Higley Industries, Inc.

    FDA warns Higley Industries over CGMP failures in OTC drug manufacturing, including untested ethanol and glycerin.

    High risk
  2. Dream Wholesale, Inc

    Dream Wholesale, an importer of frozen spinach and chickpeas, lacked required Foreign Supplier Verification Program (FSVP) checks.

    High risk
  3. Healthtex Distributors, Inc.

    FDA found Healthtex Distributors' dietary supplements adulterated for CGMP failures and misbranded for labeling violations.

    Medium
  4. EzriCare LLC

    EzriCare distributed non-sterile Artificial Tears made by a CMO with CGMP violations, linked to a Pseudomonas outbreak.

    High risk
  5. QuVa Pharma, Inc.

    FDA warned QuVa Pharma, a sterile drug outsourcing facility in Bloomsbury, NJ, of mold in its cleanest filling area and other CGMP failures.

    High risk
  6. Cipla Limited

    FDA warned Cipla about unresolved albuterol inhaler delivery complaints and contamination in sterile manufacturing at its Indore site.

    High risk
  7. National Chemical Laboratories

    National Chemical Laboratories’ OTC topical drugs were adulterated after FDA found manufacturing quality violations, including untested BZK and weak quality oversight.

    High risk
  8. Brenntag Great Lakes, LLC

    Brenntag Great Lakes failed to prevent cross-contamination of OTC hand sanitizer made on equipment shared with industrial chemicals.

    High risk
  9. Natural Relief Inc.

    Natural Relief Inc. of Coshocton, Ohio, sold two herbal capsule products as unapproved drugs and had serious supplement manufacturing violations.

    High risk
  10. ALI Pharmaceutical Manufacturing, LLC

    FDA says ALI Pharmaceutical Manufacturing failed to validate and control its porcine thyroid drug substance process, making the drug substance adulterated.

    High risk
  11. Similasan AG

    Similasan AG's ophthalmic drugs are unapproved new drugs and violate CGMP (manufacturing quality rules), FDA says.

    High risk
  12. Osmosis, LLC

    Osmosis sold unapproved drug products with disease claims and had dietary supplement CGMP and labeling violations.

    High risk
  13. K.C. Pharmaceuticals Inc.

    FDA warned K.C. Pharmaceuticals after inspections found manufacturing rule violations in sterile ophthalmic drugs, including inadequate contamination controls and cleaning validation.

    High risk
  14. Avlon Industries, Inc.

    FDA warned Avlon Industries that its over-the-counter drug manufacturing broke quality rules, citing missing identity tests for high-risk glycerin/propylene glycol and validation failures.

    High risk
  15. Jamol Laboratories, Inc.

    FDA found Jamol Laboratories making a nasal emollient under insanitary conditions and without adequate quality control, lab testing, or process validation.

    High risk
  16. Porfirios Italian Foods, Inc.

    FDA says Porfirios Italian Foods made pasta under insanitary conditions without a required food safety plan.

    High risk
  17. NAFTA Distributors Inc.

    NAFTA Distributors, an Ontario, California food importer, had no Foreign Supplier Verification Program for candies, oils and other foods it imports.

    Medium
  18. Mr. Lulu LLC

    FDA warned Mr. Lulu LLC of Claremont, California, that its OTC sunscreen drops were adulterated: no release testing, no identity testing, no batch records.

    High risk
  19. RemedyRepack, Inc.

    RemedyRepack, a drug repackager in Indiana, Pennsylvania, failed CGMP, including cleaning and beta-lactam cross-contamination controls.

    High risk
  20. New England Life Care, Inc. dba Advanced Compounding Solutions

    FDA cites Advanced Compounding Solutions for insanitary sterile-drug production and CGMP failures after a 2022 inspection.

    High risk
  21. Sure-Biochem Laboratories, LLC

    FDA says contract lab Sure-Biochem missed Burkholderia cepacia in drug samples and cites broad CGMP failures.

    High risk
  22. Pharmedica USA, LLC

    FDA found Pharmedica made ophthalmic and nasal drugs under insanitary conditions without required sterile controls.

    High risk
  23. Premier Nutra Pharma Inc.

    FDA cited Premier Nutra Pharma, a Carlsbad, California contract maker of nasal spray drugs, for CGMP violations after microbial contamination.

    High risk
  24. Omega Packaging Corp

    Omega Packaging Corp failed to test hand sanitizer ingredients and validate processes, FDA found.

    High risk
  25. Formology Lab Inc.

    FDA warned Formology Lab Inc. about manufacturing rule violations for drugs, including untested ingredients and unvalidated sunscreen processes.

    High risk
  26. Golden Bridge Gourmet, Inc. DBA Golden Bridge Enterprises

    Golden Bridge Gourmet, a California food importer, had no foreign supplier verification program (FSVP) for many imported foods, FDA says.

    Medium
  27. Gascó Industrial Corporation

    FDA cites Gascó Industrial for CGMP violations in OTC hand soap, antiseptics, and hand sanitizer, including shared equipment with industrial products.

    High risk
  28. Zing Brothers LLC

    FDA warns Zing Brothers LLC that its dietary supplements were made without required CGMP controls and have misleading labels.

    Medium
  29. Skyless, LLC

    FDA cited Skyless, LLC for CGMP failures and for selling three X-PASMO topical analgesic ointments as unapproved and misbranded drugs.

    High risk
  30. American Chinese Natural Herbs, Inc.

    FDA warned Garland, Texas-based American Chinese Natural Herbs, Inc. about adulterated (legally unsafe) dietary supplements made without required manufacturing controls and with mislabeled products.

    High risk
  31. Mark S. Denker, M.D., PA dba Palm Beach Fertility Center

    FDA warns Boca Raton fertility center over failures to screen sperm and egg donors for infectious disease risk.

    High risk
  32. Auto-Chlor System LLC

    Auto-Chlor System LLC made hand sanitizer under poor manufacturing practices and sold it as an unapproved, misbranded new drug.

    High risk
  33. Gobwa Exotic Imports Inc.

    FDA warns Gobwa Exotic Imports for lacking Foreign Supplier Verification Program for imported produce, spices, cocoa.

    Medium
  34. Manzela USA, LLC

    FDA found Manzela USA lacked required foreign supplier verification programs for imported corn chips, candy, peanuts, and Haba Enchilada.

    Medium
  35. NatureLab Corp.

    FDA warned NatureLab Corp., a Carrollton, Texas dietary supplement maker, that its products are adulterated from CGMP violations and misbranded.

    Medium
  36. Nephron SC Inc.

    Nephron SC's sterile drug manufacturing had unresolved cross-contamination and microbial contamination, making its drugs adulterated.

    High risk
  37. Forcemech International LLC

    Forcemech International, a powered wheelchair relabeler in Pearland, Texas, lacked quality system procedures and UDI labeling, FDA says.

    Medium
  38. Eksa Mills S.A. de C.V.

    FDA cited Eksa Mills for CGMP violations, including shared-equipment contamination risks, after an April 2022 inspection of its Mexican drug facility.

    High risk
  39. Sterling Pharmaceutical Services, LLC

    Sterling Pharmaceutical Services, LLC made sterile ophthalmic drugs with manufacturing violations and marketed unapproved new drugs.

    High risk
  40. Virgin Scent Inc. dba Artnaturals

    FDA warns Artnaturals after hand sanitizer tests found benzene and acetaldehyde impurities and inspection found CGMP failures.

    High risk
  41. Kuzmir Imports Inc.

    FDA warns Kuzmir Imports over missing foreign supplier verification program (FSVP) records for imported croutons, nougat spread, cashews.

    Medium
  42. Green Wave Analytical, LLC

    FDA warned Green Wave Analytical, a contract drug testing lab, over quality violations and its denied inspection access.

    High risk
  43. USA Medical LLC

    FDA: USA Medical sold unapproved COVID-19 antigen tests with false EUA claims and lacked basic quality system procedures.

    High risk
  44. Vitti Labs, LLC

    FDA warns Vitti Labs over unapproved umbilical cord and amniotic membrane products and sterile manufacturing failures.

    High risk
  45. DSP Skin Care LLC

    FDA cites DSP Skin Care for manufacturing failures and unapproved, misbranded Hongosan antifungal drugs.

    High risk
  46. Bioiberica, SAU

    FDA warned Bioiberica over unvalidated rework and missing stability testing of API batches at its Spain plant.

    High risk
  47. Valley View Milling LLC

    Valley View Milling of Seneca, Kansas, made sheep feed with copper at toxic levels that killed or injured sheep, and did not follow its own food safety procedures.

    High risk
  48. Las Dos Californias Inc DBA Dulceria los Cuates

    Las Dos Californias Inc, a San Diego food importer, lacked required foreign supplier verification programs for imported candy, seeds and Chamoy.

    Medium
  49. Evans Farms Feed

    Evans Farms Feed in Alvin, Texas, made horse feed with fumonisin above FDA's 1 ppm limit, tied to horse illnesses and one death.

    High risk
  50. Agroson’s LLC

    Agroson’s LLC lacked required FSVP checks for imported papayas and limes, FDA says.

    Medium